Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PALO ALTO, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- BlissBot, a leader in AI-driven neurodevelopmental technology, today announced the official release of StarHealing, a pioneering 6-month...
-
Hyderabad, Jan. 23, 2026 (GLOBE NEWSWIRE) -- According to the latest report by Mordor Intelligence, the dietary supplements market size is valued at USD 151.82 billion in 2026 and is projected to...
-
Washington, DC, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) applauds the House for taking decided action today to enact reforms to support Medicare...
-
Columbia, MO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Relevance, an AI visibility (GEO) and SEO agency, today announced the release of its 2026 Healthcare SEO & GEO Playbook, a practical,...
-
Springfield, Mo., Jan. 22, 2026 (GLOBE NEWSWIRE) -- New research from the American Cancer Society (ACS), published today in the Journal of the American Medical Association (JAMA), confirms a grim...
-
SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery,...
-
MINNEAPOLIS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for...
-
LOS ANGELES, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The Dr. Lauren Papa Scholarship for Healthcare Students opens its application cycle, offering undergraduate students pursuing healthcare-related...
-
4D Path to participate as exploratory biomarker collaborator in Phase II DAD-IO clinical study (NCT04724018) led by DFCI and supported by Gilead Sciences
-
Electric grid innovation to medical device monitoring, DNA sequencing, sustainable materials, and clean energy are projected to grow at CAGRs above 20%.